Mostrar el registro sencillo del ítem

Incidencia de los problemas relacionados con los medicamentos antirretrovirales para el tratamiento de la infección por HIV en pacientes hospitalizados en el Hospital Santa Clara de Bogotá

dc.contributor.authorBadillo C.A.
dc.contributor.authorBarrera L.K.
dc.contributor.authorArias G.
dc.contributor.authorTribiño G.F.
dc.contributor.authorGamboa O.A.
dc.contributor.authorGarcía J.C.
dc.contributor.authorGranada A.M.
dc.date.accessioned2024-04-17T15:15:46Z
dc.date.available2024-04-17T15:15:46Z
dc.date.issued2019
dc.identifier.citationBadillo, C.A., Barrera, L.K., Arias, G., Tribiño, G.F., Gamboa, O.A., García, J.C., Granada, A.M. Incidence of antiretroviral drug-related problems in the treatment of HIV among hospitalized patients in the Hospital Santa Clara, Bogota [Article@Incidencia de los problemas relacionados con los medicamentos antirretrovirales para el tratamiento de la infección por HIV en pacientes hospitalizados en el Hospital Santa Clara de Bogotá] (2019) Biomedica, 39 (3), art. no. 4345, pp. 561-575.es_CO
dc.identifier.otherhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85072912854&doi=10.7705%2fBIOMEDICA.4345&partnerID=40&md5=ec93e6dd47132164910ddddd3675406d
dc.identifier.urihttp://hdl.handle.net/10818/59759
dc.description4 páginas
dc.description.abstractIntroduction: The antiretroviral therapy for the treatment of the human immunodeficiency virus (HIV) is a therapeutic strategy linked to drug-related problems that cause or can cause the appearance of negative results associated with the medication. It is important, therefore, to identify their incidence, characterize them, and classify them to design strategies to minimize their impact. Objective: To estimate the overall incidence and the incidence of each one of the antiretroviral drugs-related problems in the treatment of the HIV infection in a cohort of hospitalized patients in Bogota, Colombia. Materials and methods: We conducted a descriptive, retrospective cohort study in patients aged 18 years or more diagnosed with HIV infection and under antiretroviral treatment hospitalized between January 1st, 2015, and December 31st, 2016, in the Hospital Santa Clara, Bogota. Results: The overall incidence of antiretroviral drug-related problems was 0.90 (95% CI: 0.85-0.93). The incidence of drug-drug interactions was 0.85 (95% CI: 0.80-0.90), 0.28 (95% CI: 0.22-0.35) for adverse reactions, and 0.12 (CI 95%: 0.08-0.17) for prescription errors. Conclusion: Drug-related problems should be studied, diagnosed, prevented, and treated. Their knowledge can enable health care professionals to anticipate their emergence, reduce their incidence, implement risk management plans, and optimize adherence to antiretroviral treatment. © 2019 Instituto Nacional de Salud.en
dc.language.isoenges_CO
dc.publisherBiomedicaes_CO
dc.relation.ispartofseriesBiomedica 39 (3), 561-575
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceUniversidad de La Sabanaes_CO
dc.sourceIntellectum Repositorio Universidad de La Sabanaes_CO
dc.subject.otherDrug interactionsen
dc.subject.otherDrug-related side effects and adverse reactionsen
dc.subject.otherHighly active antiretroviral therapyen
dc.subject.otherHIVen
dc.subject.otherMedication errorsen
dc.subject.otherPharmacovigilanceen
dc.titleIncidence of antiretroviral drug-related problems in the treatment of HIV among hospitalized patients in the Hospital Santa Clara, Bogotaen
dc.titleIncidencia de los problemas relacionados con los medicamentos antirretrovirales para el tratamiento de la infección por HIV en pacientes hospitalizados en el Hospital Santa Clara de Bogotáes_CO
dc.typejournal articlees_CO
dc.type.hasVersionpublishedVersiones_CO
dc.rights.accessRightsopenAccesses_CO
dc.identifier.doi10.7705/BIOMEDICA.4345


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International